Last updated on November 20, 2023
Sunrest Lifescience IPO description – The company is engaged in the marketing of OTC generic pharmaceutical products in the domestic market. Sunrest Lifescience offers a range of pharmaceutical products manufactured by third-party manufacturers. It operates in different states of India including Maharashtra, Gujarat, Madhya Pradesh, Orissa, and Rajasthan. The company has a presence in these states through trademarks registered products and/or products under registration.
Sunrest Lifescience deals in Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste. Its product portfolio comprises of wide range of drugs like Anti-Bacterial, Anti Diarrheal, AntiFungal, Anti Material, Anti Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical and Anti-inflammatory. The company has 18 registered trademarks for 32 products.
Its business operations are supported by one of its group companies and various third-party manufacturers. Sunrest Lifescience typically works on a third-party manufacturing basis or at times purchase order basis with the manufacturer of pharma products, depending upon the customer’s requirement.
Promoters of Sunrest Lifescience – Mr. Nikhilkumar Y Thakkar, Mr. Amitbhai Shambhulal Thakkar, Mr. Bhagyesh Kiritbhai Parekh, and Mr. Bharatkumar V Thakkar
Table of Contents
Sunrest Lifescience IPO Details
| Sunrest Lifescience IPO Dates | 7 – 9 November 2023 |
| Sunrest Lifescience Issue Price | INR 84 per share |
| Fresh issue | 1,291,200 shares (INR 10.85 crore) |
| Offer For Sale | Nil |
| Total IPO size | 1,291,200 shares (INR 10.85 crore) |
| Minimum bid (lot size) | 1,600 shares (INR 134,400) |
| Face Value | INR 10 per share |
| Retail Allocation | 50% |
| Listing On | NSE SME |
Sunrest Lifescience Financial Performance
| Â | FY 2021 | FY 2022 | FY 2023 | Q1 FY 2024 |
| Revenue | 16.95 | 26.89 | 24.64 | 5.64 |
| Expenses | 16.72 | 25.86 | 21.93 | 4.66 |
| Net income | 0.17 | 0.78 | 2.04 | 0.75 |
Sunrest Lifescience Offer News
- Sunrest Lifescience RHP
- Sunrest Lifescience Draft Prospectus
- ASBA IPO Forms
- Live IPO Subscription Status
- IPO Allotment Status
Sunrest Lifescience Valuations & Margins
| FY 2021 | FY 2022 | FY 2023 | |
| EPS | 0.55 | 2.59 | 6.81 |
| PE ratio | – | – | 12.33 |
| RONW (%) | 56.12 | 72.49 | 65.59 |
| NAV | – | – | 10.38 |
| EBITDA (%) | 1.62 | 4.17 | 11.89 |
| Debt/Equity | 7.72 | 2.88 | 0.64 |
Sunrest Lifescience IPO GMP Today
| Date | Consolidated IPO GMP | Kostak | Subject to Sauda |
| 18 November 2023 | 15 | – | 18,000 |
| 17 November 2023 | 15 | – | 18,000 |
| 16 November 2023 | 15 | – | 18,000 |
| 15 November 2023 | 15 | – | 18,000 |
| 14 November 2023 | 15 | – | 18,000 |
| 11 November 2023 | 15 | – | 18,000 |
| 10 November 2023 | 17 | – | 21,000 |
| 9 November 2023 | 20 | – | 25,000 |
| 8 November 2023 | 17 | – | 18,000 |
| 7 November 2023 | 12 | – | 13,000 |
| 6 November 2023 | 10 | – | 9,000 |
| 4 November 2023 | 10 | – | 9,000 |
Sunrest Lifescience IPO Subscription – Live Updates
| Category | Non-retail | Retail | Total |
|---|---|---|---|
| Shares Offered | 678,400 | 612,800 | 1,291,200 |
| 9 Nov 2023 | 26.45 | 65.74 | 45.10 |
| 8 Nov 2023 | 2.48 | 19.60 | 10.61 |
| 7 Nov 2023 | 0.55 | 5.72 | 3.00 |
Sunrest Lifescience IPO Allotment Status
Sunrest Lifescience IPO allotment status is now available on Skyline Financial Services’ website. Click on this link to get allotment status.
Sunrest Lifescience IPO Dates & Listing Performance
| IPO Opening Date | 7 November 2023 |
| IPO Closing Date | 9 November 2023 |
| Finalization of Basis of Allotment | 15 November 2023 |
| Initiation of refunds | 16 November 2023 |
| Transfer of shares to demat accounts | 17 November 2023 |
| IPO Listing Date | 20 November 2023 |
| Opening Price on NSE SME | INR 84 per share (no change) |
| Closing Price on NSE SME | INR 79.80 per share (down 5%) |
Sunrest Lifescience Offer Lead Manager
MARK CORPORATE ADVISORS PRIVATE LIMITED
404/1, The Summit Business Bay,
Sant Janabai Road (Service Lane), Off W. E. Highway,
Vile Parle (East), Mumbai-400 057, Maharashtra
Phone:Â +91 22 2612 3208
Email:Â [email protected]
Website:Â www.markcorporateadvisors.com
Sunrest Lifescience Offer Registrar
SKYLINE FINANCIAL SERVICES PRIVATE LIMITED
D-153A, First Floor, Okhla Industrial Area,
Phase-I, New Delhi, 110020
Phone:Â 011 26812682
Email:Â [email protected]
Website:Â www.skylinerta.com
Sunrest Lifescience Contact Details
SUNREST LIFESCIENCE LIMITED
FF-41, Ajay Tenament-6,
Near Canal Near Ritanagar Bus Stand,
Vastral Road, Ahmedabad-382415, Gujarat
Phone: 079 – 29918245
E-mail: [email protected]
Website: www.sunrestlifescience.com
IPO FAQs
What is the Sunrest Lifescience offer size?
Sunrest Lifescience offer size is INR 10.85 crores.
What is the Sunrest Lifescience offer price band?
Sunrest Lifescience public offer price is INR 84 per share.
What is the lot size of the Sunrest Lifescience IPO?
Sunrest Lifescience offer lot size is 1,600 shares.
What is Sunrest Lifescience IPO GMP today?
Sunrest Lifescience IPO GMP today is INR 15 per share.
What is the Sunrest Lifescience kostak rate today?
Sunrest Lifescience kostak rate today is INR NA per application.
What is Sunrest Lifescience Subject to Sauda rate today?
Sunrest Lifescience Subject to Sauda rate today is INR 18,000 per application.
